A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

Yeh, Elizabeth, Cunningham, Melissa, Arnold, Hugh, Chasse, Dawn, Monteith, Teresa, Ivaldi, Giovanni, Hahn, William C., Stukenberg, P. Todd +6 more·2004·Nature Cell Biology

DOI 10.1038/ncb1110

Cited by (796)

Items 301–400 of 796

Prolyl Isomerase Pin1-mediated Conformational Change and Subnuclear Focal Accumulation of Runx2 Are Crucial for Fibroblast Growth Factor 2 (FGF2)-induced Osteoblast Differentiation
Won‐Joon Yoon, Young‐Dan Cho, Woo-Jin Kim, Hansol Bae, Rabia Islam, Kyung Mi Woo, Jeong‐Hwa Baek, Suk‐Chul Bae, Hyun‐Mo Ryoo · 2014 · Journal of Biological Chemistry
Peptidyl-prolyl Isomerase Pin1 Controls Down-regulation of Conventional Protein Kinase C Isozymes
Hilde Abrahamsen, Audrey O’Neill, Natarajan Kannan, Nicole K. Kruse, Susan Serota Taylor, Patricia Ann Jennings, Alexandra C. Newton · 2012 · Journal of Biological Chemistry
Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers
Caroline C. Farrington, Eric Yuan, Sahar Mazhar, Sudeh Izadmehr, Lauren Hurst, Brittany L. Allen-Petersen, Mahnaz Janghorban, Eric M. Chung, Grace Wolczanski, Matthew D. Galsky et al. · 2020 · Journal of Biological Chemistry
G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia
Irene Riz, Robert G. Hawley · 2005 · Oncogene
Regulation of c-Myc Protein Abundance by a Protein Phosphatase 2A-Glycogen Synthase Kinase 3 -Negative Feedback Pathway
Liu, L., Eisenman, R. N. · 2012 · Genes & Cancer
Immortalization of Human Neural Stem Cells with the c-Myc Mutant T58A
Lidia De Filippis, Daniela Ferrari, Laura Rota Nodari, Bruno B. Amati, Evan Snyder, Angelo Luigi Vescovi · 2008 · PLoS ONE
CIP2A is overexpressed in esophageal squamous cell carcinoma
Wei Qu, Wenjuan Li, Ling Wei, Ligang Xing, Xingwu Wang, Jinming Yu · 2010 · Medical Oncology
The PHLPP2 phosphatase is a druggable driver of prostate cancer progression
Dawid Grzegorz Nowak, Ksenya Cohen‐Katsenelson, Kaitlin E. Watrud, Muhan Chen, Grinu Mathew, Vincent D. D’Andrea, Matthew F. Lee, Manojit Mosur Swamynathan, Irene Casanova‐Salas, Megan C. Jibilian et al. · 2019 · The Journal of Cell Biology
Oxidative stress-induced mitophagy is suppressed by the miR-106b-93-25 cluster in a protective manner
Cheng Zhang, Pengqing Nie, Chunliu Zhou, Yue Hu, Suling Duan, Meijia Gu, Dongxu Jiang, Yunfu Wang, Zixin Deng, Jincao Chen et al. · 2021 · Cell Death and Disease
Chromatin at the intersection of viral infection and DNA damage
Caroline E. Lilley, Mira S. Chaurushiya, Matthew D. Weitzman · 2009 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Rubratoxin A specifically and potently inhibits protein phosphatase 2A and suppresses cancer metastasis
Shun‐ichi Wada, Ihomi Usami, Yōji Umezawa, Hiroyuki Inoue, Shun‐ichi Ohba, Tetsuya Someno, Manabu Kawada, Daishiro Ikeda · 2009 · Cancer Science
Protein Phosphatase 2A Stabilizes Human Securin, Whose Phosphorylated Forms Are Degraded via the SCF Ubiquitin Ligase
Ana M. Gil-Bernabé, Francisco Romero, M. Cristina Limón‐Mortés, Marı́a Tortolero · 2006 · Molecular and Cellular Biology
Deubiquitinating c-Myc: USP36 steps up in the nucleolus
Xiao‐Xin Sun, Rosalie C. Sears, Mu‐Shui Dai · 2015 · Cell Cycle
Sonic Hedgehog Signaling in Cerebellar Development and Cancer
Wan-Chen Wang, Ryo Shiraishi, Daisuke Kawauchi · 2022 · Frontiers in Cell and Developmental Biology
The Peptidyl-Prolyl Isomerase Pin1 Regulates Cytokinesis through Cep55
Armando van der Horst, Kum Kum Khanna · 2009 · Cancer Research
The Tumor Suppressor Protein HBP1 Is a Novel c-Myc-binding Protein That Negatively Regulates c-Myc Transcriptional Activity
Julienne R. Escamilla‐Powers, Colin J. Daniel, Amy Farrell, Karyn L. Taylor, Xiaoli Zhang, Sarah A. Byers, Rosalie C. Sears · 2009 · Journal of Biological Chemistry
Antitumor mechanisms when pRb and p53 are genetically inactivated
Liang Zhu, Zhonglei Lu, Heng-tai Zhao · 2014 · Oncogene
Myc Function in Drosophila
Paola Bellosta, Peter Gallant · 2010 · Genes & Cancer
Triterpene Acid (3-O-p-Coumaroyltormentic Acid) Isolated From Aronia Extracts Inhibits Breast Cancer Stem Cell Formation through Downregulation of c-Myc Protein
Hack Sun Choi, Su‐Lim Kim, Ji Hyang Kim, Hong‐Yuan Deng, Bong‐Sik Yun, Dong‐Sun Lee · 2018 · International Journal of Molecular Sciences
Noninvasive molecular imaging of c-Myc activation in living mice
Hua Fan-Minogue, Zhongwei Cao, Ramasamy Paulmurugan, Carmel T. Chan, Tarik F. Massoud, Dean W. Felsher, Sanjiv Sam Gambhir · 2010 · Proceedings of the National Academy of Sciences
PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene
Zhuyan Guo, Anlai Wang, Weidong Zhang, Mikhail N. Levit, Qiang Gao, Claude Barberis, Michel Tabart, Jingxin Zhang, Dietmar Hoffmann, Dmitri Wiederschain et al. · 2014 · Blood
Wnt/Myc interactions in intestinal cancer: Partners in crime
Kevin Myant, Owen James Sansom · 2011 · Experimental Cell Research
Polyamine Metabolism Is Sensitive to Glycolysis Inhibition in Human Neuroblastoma Cells
M. Victoria Ruiz-Pérez, Miguel Ángel Medina, José Luis Urdiales, Tuomo A. Keinänen, Francisca Sánchez‐Jiménez · 2015 · Journal of Biological Chemistry
Viral-Mediated Noisy Gene Expression Reveals Biphasic E2f1 Response to MYC
Jeffrey V. Wong, Guang Yao, Joseph Roy Nevins, Lingchong You · 2011 · Molecular Cell
Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways
Dapeng Zhao, Zhifang Liu, Jian Ping Ding, Wenjuan Li, Yundong Sun, Han Yu, Yabin Zhou, Jiping Zeng, Chunyan Chen, Jihui Jia · 2009 · Journal of Medical Microbiology
Hyperosmotic stress contributes to mouse colonic inflammation through the methylation of protein phosphatase 2A
Laurent H. Schwartz, Mohammad Abolhassani, Mohammad Pooya, Jean‐Marc Steyaert, Xavier Wertz, Maurice Israël, Adeline Guais, Philippe Chaumet‐Riffaud · 2008 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Degrasyn Activates Proteasomal-Dependent Degradation of c-Myc
Geoffrey A. Bartholomeusz, Moshe Talpaz, William G. Bornmann, Ling-Yuan Kong, Nicholas J. Donato · 2007 · Cancer Research
Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis
Jing Han, Yangfeng Zhang, Jing Xu, Tao Zhang, Hongsheng Wang, Zhuoying Wang, Yafei Jiang, Lei Zhou, Mengkai Yang, Yingqi Hua et al. · 2020 · Cancer Letters
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
Ka Iong Chan, Siyuan Zhang, Guodong Li, Yida Xu, Liao Cui, Yitao Wang, Huanxing Su, Wen Tan, Zhangfeng Zhong · 2024 · Aging and Disease
Detailed clinicopathological characteristics and possible lymphomagenesis of type II intestinal enteropathy-associated T-cell lymphoma in Japan
Kanta Kikuma, Kozue Yamada, Shotaro Nakamura, Akiko Ogami, Satoshi Nimura, Minako Hirahashi, Hirotoshi Yonemasu, Shogo Urabe, Shinji Naito, Yasumasa Matsuki et al. · 2014 · Human Pathology
Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPα
Deepak Bararia, Arun Kumar Trivedi, A A Peer Zada, Philipp A. Greif, Medhanie Assmelash Mulaw, Maximilian Christopeit, Wolfgang Hiddemann, Stefan K. Bohlander, Gerhard Behre · 2008 · Leukemia
ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
Yu Chen, Chi Zhou, Wei Ji, Zhichao Mei, Bo Hu, Wei Zhang, Dawei Zhang, Jing Wang, Xing Liu, Gang Ouyang et al. · 2016 · Nature Communications
eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis
Yan Cheng, Xingcong Ren, Yun Yuan, Y Shan, L Li, Xiaochi Chen, L Zhang, Yoshinori Takahashi, Jun Yang, B Han et al. · 2016 · Oncogene
PP2A-dependent TFEB activation is blocked by PIKfyve-induced mTORC1 activity
Junya Hasegawa, Emi Y. Tokuda, Yao Yao, Takehiko Sasaki, Ken Inoki, Lois S. Weisman · 2022 · Molecular Biology of the Cell
Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells
Yusuke Nakatsu, Takeshi Yamamotoya, Koji Ueda, Hiraku Ono, Masa-Ki Inoue, Yasuka Matsunaga, Akifumi Kushiyama, Hideyuki Sakoda, Midori Fujishiro, Akio Matsubara et al. · 2019 · Cancer Letters
PP2A Inactivation Mediated by <i>PPP2R4</i> Haploinsufficiency Promotes Cancer Development
Sents, Ward, Meeusen, Bob, Kalev, Petar, Radaelli, Enrico, Sagaert, Xavier, Miermans, Eline, Haesen, Dorien, Lambrecht, Caroline, Dewerchin, Mieke, Carmeliet, Peter et al. · 2017 · Cancer Research
U0126: Not only a MAPK kinase inhibitor
Yijie You, Yunlian Niu, Jian Zhang, Sheng Huang, Peiyuan Ding, Fengbing Sun, Xuhui Wang · 2022 · Frontiers in Pharmacology
Expanding the functional role of long noncoding RNAs
Per Johnsson, Kevin V. Morris · 2014 · Cell Research
LncRNAs in vertebrates: Advances and challenges
Allison C. Mallory, Alena Shkumatava · 2015 · Biochimie
Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc
Luana D’Artista, Andrea Bisso, Andrea Piontini, Mirko Doni, Alessandro Verrecchia, Theresia R. Kress, Marco J. Morelli, Giannino Del Sal, Bruno B. Amati, Stefano Campaner · 2016 · Oncotarget
Metformin blocks MYC protein synthesis in colorectal cancer via m TOR ‐4 EBP ‐e IF 4E and MNK1‐e IF 4G‐e IF 4E signaling
Peng Shen, Lucas Charles Reineke, Erik Knutsen, Meng Chen, Martin Pichler, Hui Yvonne Ling, George A. Călin · 2018 · Molecular Oncology
BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition
Weihong Niu, Yanwei Luo, Yao Zhou, Mengna Li, Chunchun Wu, Yumei Duan, Heran Wang, Songqing Fan, Zheng Li, Wei Xiong et al. · 2020 · Journal of Experimental & Clinical Cancer Research
The inflammatory kinase IKKα phosphorylates and stabilizes c-Myc and enhances its activity
Bernhard Moser, Bernhard Hochreiter, José Basílio, Viola Gleitsmann, Anja Panhuber, Alan Pardo-Garcia, Bastian Hoesel, Manuel Salzmann, Ulrike Resch, Mamoona Noreen et al. · 2021 · Molecular Cancer
Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic Leukemia
Marissa Rashkovan, Robert Alberó, Francesca Gianni, Pablo Perez-Duran, Hannah I. Miller, Adam L. Mackey, Elisabeth M. Paietta, Martin S. Tallman, Jacob M. Rowe, Mark R. Litzow et al. · 2021 · Cancer Discovery
Pin1 inhibits PP2A-mediated Rb dephosphorylation in regulation of cell cycle and S-phase DNA damage
Y Tong, Haoqiang Ying, Ruikang Liu, L. Li, Johann S. Bergholz, Z-X J Xiao · 2015 · Cell Death and Disease
The role of Pin1 in the development and treatment of cancer
Sang‐Hyun Min, Xiao Zhen Zhou, Kun Ping Lu · 2016 · Archives of Pharmacal Research
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia
Swagata Goswami, Rajeswaran Mani, Jessica Judith Nunes, Chi‐Ling Chiang, Kevan Zapolnik, Eileen Y. Hu, Frank W. Frissora, Xiaokui Mo, Logan A. Walker, Pearlly S. Yan et al. · 2021 · Blood
Myc proteins in brain tumor development and maintenance
Fredrik J. Swartling · 2012 · Upsala Journal of Medical Sciences
Pharmacological Targeting of Catalyzed Protein Folding: The Example of Peptide Bond cis/trans Isomerases
Frank Edlich, Gunter S. Fischer · 2005 · Handbook of experimental pharmacology
KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc
Eun Jung Kim, Sung-Hak Kim, Xiong Jie Jin, Xun Jin, Hyunggee Kim · 2017 · Cell Death and Differentiation
The impact of phosphatases on proliferative and survival signaling in cancer
Goutham Narla, Jaya Sangodkar, Christopher B. Ryder · 2018 · Cellular and Molecular Life Sciences
Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer
Cassandra P. Nader, Aylin Cidem, Nicole M. Verrills, Alaina Jean Ammit · 2019 · Respiratory Research
A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors
Zhaojun Qiu, Pengyan Fa, Tao Liu, Chandra Bhushan Prasad, Shanhuai Ma, Zhipeng Hong, Ernest Ricky Chan, Hongbing Wang, Zaibo Li, Kai He et al. · 2020 · Cancer Research
Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis
Yi Qiu, Mingjiang Xu, Suming Huang · 2021 · Blood
Unravelling similarities and differences in the role of circular and linear PVT1 in cancer and human disease
Debora Traversa, Giorgia Simonetti, Doron Tolomeo, Grazia Visci, Gemma Macchia, Martina Ghetti, Giovanni Martinelli, Lasse S. Kristensen, Clelia Tiziana Storlazzi · 2021 · British Journal of Cancer
A phosphorylated prodrug for the inhibition of Pin1
Song Zhao, Felicia A. Etzkorn · 2007 · Bioorganic & Medicinal Chemistry Letters
N-terminal Truncation of Antiapoptotic MCL1, but Not G2/M-induced Phosphorylation, Is Associated with Stabilization and Abundant Expression in Tumor Cells
Alfredo De Biasio, Julie A. Vrana, Ping Zhou, Liping Qian, Christine K. Bieszczad, Karen E. Braley, Aaron M. Domina, Steven Jay Weintraub, John M. Neveu, William S. Lane et al. · 2007 · Journal of Biological Chemistry
CIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression
Armin Wiegering, Christina Pfann, Friedrich Wilhelm Uthe, Christoph Otto, Lukas Rycak, Uwe Mäder, Martin Gasser, Anna-Maria Waaga-Gasser, Martin Eilers, Christoph‐Thomas Germer · 2013 · PLoS ONE
Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers
Caroline C. Farrington, Eric Yuan, Sahar Mazhar, Sudeh Izadmehr, Lauren Hurst, Brittany L. Allen-Petersen, Mahnaz Janghorban, Eric M. Chung, Grace Wolczanski, Matthew D. Galsky et al. · 2019 · Journal of Biological Chemistry
Overcoming tamoxifen resistance in oestrogen receptor‐positive breast cancer using the novel thiosemicarbazone anti‐cancer agent, DpC
Sundus Naila Maqbool, Syer Choon Lim, Kyung Chan Park, Rumeza Hanif, Des Raymond Richardson, Patric J. Jansson, Žaklina Kovačević · 2020 · British Journal of Pharmacology
AMBRA1 and BECLIN 1 interplay in the crosstalk between autophagy and cell proliferation
Valentina Cianfanelli, Melania D’Orazio, Francesco Cecconi · 2015 · Cell Cycle
SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62
Wenli Wang, P Liao, M Shen, Tianyu Chen, Yan Chen, Yixiang Chen and Baohua Wang Huiyong Li, Xia Lin, Xin Ge, Peijun Wang · 2015 · Oncogene
Protein Kinase A Regulates MYC Protein through Transcriptional and Post-translational Mechanisms in a Catalytic Subunit Isoform-specific Manner
Achuth Padmanabhan, Xiang Li, Charles J. Bieberich · 2013 · Journal of Biological Chemistry
ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis
Kevin O’Hayer, Donita C. Brady, Christopher M. Counter · 2009 · Carcinogenesis
Convergence of cMyc and β‐catenin on Tcf7l1 enables endoderm specification
Gillian M. Morrison, Roberta Scognamiglio, Andreas Trumpp, Austin G Smith · 2015 · The EMBO Journal
The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias
Raffaella Pippa, Maria Dolores Odero · 2020 · Cells
Peptidyl-Prolyl Isomerase Pin1 Markedly Enhances the Oncogenic Activity of the Rel Proteins in the Nuclear Factor-κB Family
Gaofeng Fan, Yongjun Fan, Nupur Gupta, Isao Matsuura, Fang Liu, Xiao Zhen Zhou, Kun Ping Lu, Céline Gélinas · 2009 · Cancer Research
The insulin and IGF signaling pathway sustains breast cancer stem cells by IRS2/PI3K-mediated regulation of MYC
Jisun Lee, Michael W. Lero, Jose Mercado-Matos, Sha Zhu, Minjeong Jo, Claire E. Tocheny, Jennifer S. Morgan, Leslie M. Shaw · 2022 · Cell Reports
mTORC2 promotes cell survival through c-Myc–dependent up-regulation of E2F1
Zhipeng Zou, Juan Chen, Anling Liu, Xuan Zhou, Qiancheng Song, Chunhong Jia, Zhenguo Chen, Jun Lin, Cuilan Yang, Ming Li et al. · 2015 · The Journal of Cell Biology
Regulating Fbw7 on the road to cancer
Wenshan Xu, Lyudmyla Taranets, Nikita Popov · 2015 · Seminars in Cancer Biology
Celastrol inhibits chondrosarcoma proliferation, migration and invasion through suppression CIP2A/c-MYC signaling pathway
Jinhui Wu, Muchen Ding, Ningfang Mao, Yungang Wu, Chao Wang, Jiabin Yuan, Miao Xiong, Jingfeng Li, Zhicai Shi · 2017 · Journal of Pharmacological Sciences
A Conserved Pathway That Controls c-Myc Protein Stability through Opposing Phosphorylation Events Occurs in Yeast
Julienne R. Escamilla‐Powers, Rosalie C. Sears · 2006 · Journal of Biological Chemistry
Identification of Domains Responsible for Ubiquitin-Dependent Degradation of dMyc by Glycogen Synthase Kinase 3β and Casein Kinase 1 Kinases
Margherita Galletti, Sara Riccardo, Federica Parisi, Carlina Lora, Mahesh Saqcena, Leinny Rivas, Bonnie Wong, Alexis L. Serra, Florenci Serras, Daniela Grifoni et al. · 2009 · Molecular and Cellular Biology
Negative Regulation of Peptidyl-Prolyl Isomerase Activity by Interdomain Contact in Human Pin1
Xinsheng Wang, Brendan J. Mahoney, Meiling Zhang, John S. Zintsmaster, Jeffrey W. Peng · 2015 · Structure
SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell
Hao Liu, Yixue Gu, Jiang Yin, Guopei Zheng, Chenkun Wang, Zhijie Zhang, Min Deng, Jifang Liu, Xiaoting Jia, Zhimin He · 2014 · Cellular Signalling
Protein phosphatases in chromatin structure and function
Raquel Sales Gil, Paola Vagnarelli · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth
Shaikamjad Umesalma, Courtney A. Kaemmer, Jordan L. Kohlmeyer, Blake L. Letney, Angela M. Schab, Jacqueline A. Reilly, Ryan Michael Sheehy, Jussara Hagen, Nitija Tiwari, Fenghuang Zhan et al. · 2019 · Journal of Clinical Investigation
Oncogenic Hijacking of the PIN1 Signaling Network
Alessandro Zannini, Alessandra Rustighi, Elena Campaner, Giannino Del Sal · 2019 · Frontiers in Oncology
FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
Wenyue Shen, Quanwei Zhou, Chenxi Peng, Jiaheng Li, Qizhi Yuan, Hecheng Zhu, Mingwen Zhao, Xingjun Jiang, Weidong Liu, Caiping Ren · 2022 · Frontiers in Oncology
Pin1 Associates with and Induces Translocation of CRTC2 to the Cytosol, Thereby Suppressing cAMP-responsive Element Transcriptional Activity*
Yusuke Nakatsu, Hideyuki Sakoda, Akifumi Kushiyama, Hiraku Ono, Midori Fujishiro, Nanao Horike, Masayasu Yoneda, Haruya Ohno, Yoshihiro Tsuchiya, Hideaki Kamata et al. · 2010 · Journal of Biological Chemistry
GLIPR1 Suppresses Prostate Cancer Development through Targeted Oncoprotein Destruction
Likun Li, Chengzhen Ren, Guang Yang, Elmoataz Abdel Fattah, Alexei A. Goltsov, Soo Mi Kim, Ju‐Seog Lee, Sanghee Park, Francesco John DeMayo, Michael Ittmann et al. · 2011 · Cancer Research
MYC Gene Delivery to Adult Mouse Utricles Stimulates Proliferation of Postmitotic Supporting Cells In Vitro
Joseph C. Burns, James J. Yoo, Anthony Atala, John D. Jackson · 2012 · PLoS ONE
Guanylyl Cyclase C in Colorectal Cancer: Susceptibility Gene and Potential Therapeutic Target
Jieru Egeria Lin, Peng Li, Giovanni Mario Pitari, Stephanie Schulz, Scott Arthur Waldman · 2009 · Future Oncology
Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia
Nameeta P. Richard, Raffaella Pippa, Megan M. Cleary, Alka Puri, Deanne Tibbitts, Shawn Mahmood, Dale J. Christensen, Sophia Jeng, Shannon K. McWeeney, Alfred Thomas Look et al. · 2016 · Oncotarget
Phosphorylation-Specific Peptidyl-Prolyl Isomerization of Neuronal Cytoskeletal Proteins by Pin1: Implications for Therapeutics in Neurodegeneration
Parvathi Rudrabhatla, Harish C. Pant · 2010 · Journal of Alzheimer s Disease
Nickel compounds induce apoptosis in human bronchial epithelial Beas-2B cells by activation of c-Myc through ERK pathway
Qin Li, Ting-Chung Suen, Hong Sun, Adriana Arita, Max Costa · 2008 · Toxicology and Applied Pharmacology
The Immunomodulatory Benzodiazepine Bz-423 Inhibits B-Cell Proliferation by Targeting c-Myc Protein for Rapid and Specific Degradation
Thomas B. Sundberg, Gina M. Ney, Chitra Subramanian, Anthony W. Opipari, Gary D. Glick · 2006 · Cancer Research
DNA tumor viruses — the spies who lyse us
Clodagh C. O’Shea · 2004 · Current Opinion in Genetics & Development
Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer
Malone, Tom, Schäfer, Lea, Simon, Nathalie, Heavey, Susan, Cuffe, Sinead, Finn, Stephen, Moore, Gillian, Gately, Kathy · 2020 · Pharmacology & Therapeutics
MYC degradation: deubiquitinating enzymes enter the dance
Bruno B. Amati, Victor Javier Sanchez-Arevalo Lobo · 2007 · Nature Cell Biology
microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13
Han Han, Yuxing Chen, Li Cheng, Edward V. Prochownik, Youjun Li · 2016 · Oncotarget
MYC, Cell Competition, and Cell Death in Cancer: The Inseparable Triad
Simone Di Giacomo, Manuela Sollazzo, Simona Paglia, Daniela Grifoni · 2017 · Genes
Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression
Hongyu Li, Shixuan Wang, Tao Zhu, Jinhua Zhou, Qian Xu, Yunping Lu, Ding Ma · 2006 · Oncology Reports
Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of Myc.
Takuya Fukazawa, Yutaka Maeda, Junji Matsuoka, Tomoki Yamatsuji, Kaoru Shigemitsu, Ichiro Morita, Francesco Faiola, Mary L. Durbin, Laura Soucek, Yoshio Naomoto · 2010 · PubMed
IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation
Yavuz Oktay, Ege Ülgen, Özge Can, Cemaliye Boylu Akyerli, Şirin Yüksel, Yiğit Erdemgil, İlknur Melis Durası, Octavian Henegariu, Paolo Nanni, Nathalie Selevsek et al. · 2016 · Scientific Reports
MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia
Raffaella Pippa, Ana Dominguez, Raquel Malumbres, Akinori Endo, Elena Arriazu, Nerea Marcotegui, Elizabeth Guruceaga, Maria Dolores Odero · 2016 · Oncotarget
The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics
Zhao Deng, Des Raymond Richardson · 2023 · Pharmacological Reviews
Repression of SRF target genes is critical for Myc‐dependent apoptosis of epithelial cells
Katrin E. Wiese, Heidi M. Haikala, Björn von Eyß, Elmar Wolf, Cyril Esnault, Andreas Rosenwald, Richard Treisman, Juha T. Klefström, Martin Eilers · 2015 · The EMBO Journal
USP28 is a potential prognostic marker for bladder cancer
Guiying Guo, Yangyang Xu, Mancheng Gong, Yan Wei Cao, Ruihua An · 2013 · Tumor Biology
EYA1's Conformation Specificity in Dephosphorylating Phosphothreonine in Myc and Its Activity on Myc Stabilization in Breast Cancer
Jun Li, Yoel Rodrı́guez, Chunming Cheng, Lei Zeng, Elaine Y.M. Wong, Chelsea Y. Xu, Ming‐Ming Zhou, Pin‐Xian Xu · 2016 · Molecular and Cellular Biology